U
MD icon

UBS’s Pediatrix Medical MD Stock Holding History

UBS’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300
Closed -$16K – 10629
2013
Q4 		$16K Buy
+300
New +$16.1K ﹤0.01% 8424

Other funds holding MD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

UBS's MD Position: Q3 2014 in Review

UBS reduced its Pediatrix Medical (MD) stake by 2.6% in Q3 2014, selling an estimated $124K and leaving 82,332 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

UBS first reported a position in MD in Q2 2013 and has held it in 6 quarters since. The position peaked at $8.27M in Q1 2014. 332 funds tracked by Wall St. Rank hold MD as of Q3 2014.

  • UBS held 82,332 shares of Pediatrix Medical worth $4.51M as of Q3 2014.
  • UBS sold 2,182 Pediatrix Medical shares in Q3 2014, an estimated $124K.
  • Pediatrix Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2130 holding.
  • UBS first reported a position in Pediatrix Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Pediatrix Medical position peaked at $8.27M in Q1 2014.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.